Yoon et al., 2014 - Google Patents
An activin A/BMP2 chimera, AB204, displays bone‐healing properties superior to those of BMP2Yoon et al., 2014
View PDF- Document ID
- 7937112141006028277
- Author
- Yoon B
- Esquivies L
- Ahn C
- Gray P
- Ye S
- Kwiatkowski W
- Choe S
- Publication year
- Publication venue
- Journal of Bone and Mineral Research
External Links
Snippet
Recombinant bone morphogenetic protein 2 (rhBMP2) has been used clinically to treat bone fractures in human patients. However, the high doses of rhBMP2 required for a therapeutic response can cause undesirable side effects. Here, we demonstrate that a novel Activin …
- 102100005377 BMP2 0 title abstract description 123
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yoon et al. | An activin A/BMP2 chimera, AB204, displays bone‐healing properties superior to those of BMP2 | |
| Wang et al. | Exosomes derived from miR-155-5p–overexpressing synovial mesenchymal stem cells prevent osteoarthritis via enhancing proliferation and migration, attenuating apoptosis, and modulating extracellular matrix secretion in chondrocytes | |
| Xu et al. | High‐dose TGF‐β1 impairs mesenchymal stem cell–mediated bone regeneration via Bmp2 inhibition | |
| Sun et al. | The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts | |
| Liu et al. | GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation | |
| Brylka et al. | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development | |
| Montgomery et al. | A novel osteogenic oxysterol compound for therapeutic development to promote bone growth: activation of hedgehog signaling and osteogenesis through smoothened binding | |
| Okuchi et al. | Wnt-modified materials mediate asymmetric stem cell division to direct human osteogenic tissue formation for bone repair | |
| Serbest et al. | The irisin hormone profile and expression in human bone tissue in the bone healing process in patients | |
| Liu et al. | Loss of menin in osteoblast lineage affects osteocyte–osteoclast crosstalk causing osteoporosis | |
| Su et al. | Neurotrophin‐3 induces BMP‐2 and VEGF activities and promotes the bony repair of injured growth plate cartilage and bone in rats | |
| Kong et al. | Conditioned media from endothelial progenitor cells cultured in simulated microgravity promote angiogenesis and bone fracture healing | |
| Zhu et al. | Combined bone morphogenetic protein‐2 and− 7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model | |
| Xi et al. | IGFBP‐2 directly stimulates osteoblast differentiation | |
| Fu et al. | Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice | |
| Huang et al. | miR-19b enhances osteogenic differentiation of mesenchymal stem cells and promotes fracture healing through the WWP1/Smurf2-mediated KLF5/β-catenin signaling pathway | |
| Xiong et al. | IL‐10 induces MC3T3‐E1 cells differentiation towards osteoblastic fate in murine model | |
| Ouyang et al. | LncRNA ENST00000563492 promoting the osteogenesis–angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by functions as a ceRNA for miR-205-5p | |
| Wang et al. | IL-1β increases asporin expression via the NF-κB p65 pathway in nucleus pulposus cells during intervertebral disc degeneration | |
| Xu et al. | Small extracellular vesicle-mediated miR-320e transmission promotes osteogenesis in OPLL by targeting TAK1 | |
| Xiao et al. | BMPER enhances bone formation by promoting the osteogenesis-angiogenesis coupling process in mesenchymal stem cells | |
| Lee et al. | Inhibition of STAT5A promotes osteogenesis by DLX5 regulation | |
| Xiong et al. | The lncRNA Rhno1/miR-6979-5p/BMP2 axis modulates osteoblast differentiation | |
| Martin et al. | NVP‐BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells | |
| Suh et al. | Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis |